🇺🇸 FDA

Intelligence Platform

Patents

Browse 1,164 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9896509

Use of antagonists of the interaction between HIV GP120 and α4β7 integrin

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9890369

Cytolethal distending toxin subunit B conjugated or fused to Bacillus anthracis toxin leth

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9889115

Fitness assay and associated methods

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9884104

Live attenuated virus vaccines for la crosse virus and other bunyaviridae

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9879065

T cell receptors recognizing MHC class II-restricted MAGE-A3

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9879231

Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertio

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9873702

Heterocyclic compounds as biogenic amine transport modulators

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9867830

Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydr

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9868954

Reduction of TGFβ signaling in myeloid cells in the treatment of cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9868774

Anti-CD22 chimeric antigen receptors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9862679

Potent and selective inhibitors of monoamine transporters; method of making; and use there

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9856313

Epitope of RSV fusion protein and antibody recognizing the same

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9856453

Compositions and methods for prevention or treatment of neoplastic disease in a mammalian

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9855330

Granulysin in immunotherapy

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9855298

Methods of conditioning patients for T cell therapy

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9850468

Infectious hepatitis E virus genotype 3 recombinants

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9845350

Monoclonal antibodies that react with the capsule of bacillus anthracis

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9833519

Methods for the diagnosis and treatment of sjögren's syndrome

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9827223

Selective ablation of pain-sensing neurons by administration of a vanilloid receptor agoni

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9820965

Biologically active macrolides, compositions, and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9822162

Anti-human papillomavirus 16 E6 T cell receptors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9815887

Monoclonal antibodies that neutralize a norovirus

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9808458

Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9803022

Mesothelin domain-specific monoclonal antibodies and use thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted